ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology. Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Science Citation Index Expanded, Journal of Citation Reports, Index Medicus/MEDLINE, Scopus, EMBASE/Excerpta Medica, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.1

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.308

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.397

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Special article

A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

Consenso multidisciplinar sobre idoneidad farmacológica en cáncer de próstata hormono-sensible metastásico

A. Borque-Fernandoa,

Corresponding author

aborque@salud.aragon.es

Corresponding author.

, M.A. Calleja-Hernándezb, J.M. Cózar-Olmoc, A. Gómez-Iturriagad, D.A. Pérez-Fentese, J. Puente-Vázquezf, M. Rodrigo-Aliagag, M. Undah, J.L. Álvarez-Ossorioi

a Servicio de Urología, Hospital Universitario Miguel Servet, Zaragoza, Spain, IIS-Aragón, Spain

b Servicio de Farmacia, Hospital Universitario Virgen Macarena, Sevilla, Spain

c Servicio de Urología, Hospital Universitario Virgen de las Nieves, Granada, Spain

d Servicio de Oncología Radioterápica, Hospital Universitario Cruces, Biocruces Bizkaia Health Research Insitute, Barakaldo, Bizkaia, Spain

e Servicio de Urología, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, A Coruña, Spain

f Servicio de Oncología Médica, Hospital Clínico Universitario San Carlos, Madrid, Spain

g Servicio de Urología, Hospital General Universitario de Castellón, Castellón. Spain

h Servicio de Urología, Hospital Universitario Basurto, Bilbao, Bizkaia, Spain

i Servicio de Urología Hospital Universitario Puerta del Mar., Presidente de la Asociación Española de Urología, Cádiz, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 21735786
Original language: English

DOI:10.1016/j.acuroe.2022.12.004

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 March	1	0	1
2023 October	1	2	3
2023 September	2	5	7
2023 August	0	2	2
2023 May	1	2	3
2023 April	11	2	13
2023 March	5	0	5

Follow this link to access the full text of the article

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter